Evidence map›Paper›PMID 30842738›Full record

ArticleFrontiers in pharmacology2019

Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics.

Xuejiao Cui, Qingxia Yang, Bo Li, Jing Tang, Xiaoyu Zhang, Shuang Li, Fengcheng Li, Jie Hu, Yan Lou, Yunqing Qiu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xuejiao CuiCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Qingxia YangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Bo LiSchool of Pharmaceutical Sciences and Collaborative Innovation Center for Brain Science, Chongqing University, Chongqing, China.
Jing TangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Xiaoyu ZhangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Shuang LiCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Fengcheng LiCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Jie HuSchool of International Studies, Zhejiang University, Hangzhou, China.
Yan LouZhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Yunqing QiuZhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Weiwei XueSchool of Pharmaceutical Sciences and Collaborative Innovation Center for Brain Science, Chongqing University, Chongqing, China.
Feng ZhuCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Chongqing University · CNZhejiang University · CNFirst Affiliated Hospital Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of the extended period of clinic data collection and huge size of analyzed samples, the long-term and large-scale pharmacometabonomics profiling is frequently encountered in the discovery of drug/target and the guidance of personalized medicine. So far, integration of the results (

Indexed as

classification capacitydirect data mergingfalse discovery ratelong-term and large-scale metabolomicsrobustness

Identifiers

PMID30842738
PMCPMC6391323
OpenAlexW2915941906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.